Team

A seasoned pharmaceutical physician with over 30 years of experience across Big Pharma and biotech sectors. Malcolm’s expertise spans the entire development lifecycle from Phase I–III across multiple therapeutic categories with special emphasis in Women’s Health. Malcolm has also built and successfully exited three Life Science companies. Other areas of focus include accelerating patient recruitment and implementing digital marketing strategies (DTC/EHR) for clinical and commercial success.

Scientist-entrepreneur bridging the gap between bench research and boardroom strategy. Deep expertise in product development, clinical trial design (P0–P3), AI, M&A sourcing, diagnostics, drug delivery, and biotech operations. Brings a hands-on operator mindset to accelerating scientific innovation into market value.

A biopharma CCO and commercial architect with 25+ years of experience taking products from clinical hypothesis to launch. Catherine has led or co-led launches generating $1B+ in annual revenue and built commercial organizations at four companies. She engages at the TPP stage, helping shape endpoints, strengthen labels, and prepare for commercialization.

A finance veteran with over 27 years of experience in Private Equity, Venture Capital, and strategic biopharma advisory. David is a FINRA-registered dealmaker specializing in both buy-side and sell-side M&A, offering deep expertise in structuring complex transactions that maximize shareholder value. His dual background in science and finance allows him to uniquely assess asset potential and navigate deal dynamics.

Certified Public Accountant with more than 20 years’ experience serving the biotechnology and life sciences community. Her experience includes budgeting; financial reporting, including SEC filings (10-K, 10-Q, and S-1); organizational policies; internal controls; contract review; and support for startup companies preparing for mergers, acquisitions, and IPOs.

Former Vice President at Sanofi with 25 years of leadership experience at Sanofi and Novartis. Expert in commercial execution, sales force effectiveness, field training, and designing high-impact omnichannel engagement strategies for product launches.

Global market access and pricing strategist with 25+ years of experience in commercial development, patient outcomes research and HE/HTA evidence generation. Deep expertise in patient journey research and resolving access friction points across US, EU, Japan, and APAC markets.

With over 36 years of investment and advisory experience, Maureen brings a wealth of capital markets expertise. As a former sell-side research analyst and hedge fund portfolio manager, she specializes in guiding companies through IPO readiness, crafting compelling corporate narratives, and building sophisticated financial models to secure valuation. Proven record of supporting C-suite executives across biotechnology, healthcare services, and medtech companies. Strong in competitive positioning and company valuations.

A digital marketing and brand strategy consultant with over 25 years of experience helping businesses - from startups to multinationals - build their online presence and grow revenue. Charles has served clients across healthcare, biotechnology, law, real estate, hospitality, and action sports, bringing a hands-on, results-driven approach to every engagement. Specializing in AI-powered SEO, WordPress development, paid media, and omni-channel strategy, delivering measurable improvements in lead generation and client retention.

Biotechnology executive and advisor with 20+ years of experience building platform biotech companies and creating clinical-stage assets across multiple therapeutic modalities. Experienced in aligning platform strategy, pipeline design, IP creation, and regulatory execution to drive clear value inflection points for investors and partners. Experience spans IND-enabling through Phase 3 development, global FDA/EMA engagement, and strategic pharmaceutical partnerships.

Commercial strategy and corporate development executive with over 15 years of experience guiding life sciences and healthcare technology organizations through growth. Brett’s career spans the product lifecycle, from development and regulatory strategy to market access and commercialization, with experience across the US, Europe, Asia, and Australia. His work includes early-stage startups and organizations such as Genentech, Novartis, Oracle, Medidata, and Komodo Health, aligning product innovation with market opportunity.

Corporate strategist and legal expert advising on complex transactions including IPOs, M&A, and licensing deals. Over 25 years of experience as a general counsel and member of senior leadership in public clinical and commercial stage biotech companies. Serves as a critical liaison between leadership teams, legal counsel, and investment bankers to streamline deal execution and align corporate strategy with regulatory requirements.